SCHEMBL7413183

SCHEMBL7413183

CC(CCC1CCCCC1)(NC(=O)c1ccncc1)C(=O)N(Cc1ccccc1)C1(C#N)CCNC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSS P25774 7/20 0.38
CTSL P07711 4/20 0.38
CTSB P07858 3/20 0.38
ALDH1A1 P00352 3/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NAMPT P43490 1/20 0.32
ACHE P22303 2/20 0.32
CTSK P43235 2/20 0.32
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
BCHE P06276 1/20 0.31
SLC2A1 P11166 1/20 0.31
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7413188 0.76 CTSS (0.39) CTSSCTSLCTSBALDH1A1CTSK
SCHEMBL7413191 0.75 CTSS (0.37) CTSSCTSLCTSBALDH1A1KDM4E
SCHEMBL7419135 0.71 CTSS (0.45) CTSSCTSLCTSBCTSKMAPK14
SCHEMBL7417228 0.70 CTSL (0.44) CTSSCTSLCTSBCTSK
SCHEMBL7014338 0.69 CTSS (0.44) CTSSCTSLCTSBALDH1A1CTSK
SCHEMBL7419241 0.69 CTSL (0.43) CTSSCTSLCTSBALDH1A1CTSK
SCHEMBL7419245 0.69 SIGMAR1 (0.41) CTSSCTSLCTSBALDH1A1CTSK
SCHEMBL7419141 0.68 AGER (0.39) LMNAHTTNPSR1
SCHEMBL6371524 0.68 L3MBTL1 (0.40) CTSSALDH1A1CTSKMAPK1KMT2A
SCHEMBL7417235 0.67 L3MBTL1 (0.35) ALDH1A1KMT2AKDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed